Cargando…
Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754148/ https://www.ncbi.nlm.nih.gov/pubmed/32506559 http://dx.doi.org/10.1111/ajt.16104 |
_version_ | 1783626136168693760 |
---|---|
author | Kotsopoulos, Angela M. Jansen, Nichon E. Vos, Piet Witjes, Marloes Volbeda, Meint Epker, Jelle L. Sonneveld, Hans P. C. Simons, Koen S. Bronkhorst, Ewald M. van der Hoeven, Hans G. Abdo, Wilson F. |
author_facet | Kotsopoulos, Angela M. Jansen, Nichon E. Vos, Piet Witjes, Marloes Volbeda, Meint Epker, Jelle L. Sonneveld, Hans P. C. Simons, Koen S. Bronkhorst, Ewald M. van der Hoeven, Hans G. Abdo, Wilson F. |
author_sort | Kotsopoulos, Angela M. |
collection | PubMed |
description | Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time from admission to family approach, influences family consent rates. Such insights could be important in improving the clinical practice of potential cDCD donors. In a prospective multicenter observational study, we evaluated the impact of timing and of the clinical factors during the end‐of‐life decision‐making process in potential cDCD donors. Characteristics and medication use of 409 potential cDCD donors admitted to the intensive care units (ICUs) were assessed. End‐of‐life decision‐making was made after a mean time of 97 hours after ICU admission and mostly during the day. Intracranial hemorrhage or ischemic stroke and a high APACHE IV score were associated with a short decision‐making process. Preserved brainstem reflexes, high Glasgow Coma Scale scores, or cerebral infections were associated with longer time to decision‐making. Our data also suggest that the organ donation request could be made shortly after the decision to stop active treatment and consent rates were not influenced by daytime or nighttime or by the duration of the ICU stay. |
format | Online Article Text |
id | pubmed-7754148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77541482020-12-23 Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors Kotsopoulos, Angela M. Jansen, Nichon E. Vos, Piet Witjes, Marloes Volbeda, Meint Epker, Jelle L. Sonneveld, Hans P. C. Simons, Koen S. Bronkhorst, Ewald M. van der Hoeven, Hans G. Abdo, Wilson F. Am J Transplant Brief Communications Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time from admission to family approach, influences family consent rates. Such insights could be important in improving the clinical practice of potential cDCD donors. In a prospective multicenter observational study, we evaluated the impact of timing and of the clinical factors during the end‐of‐life decision‐making process in potential cDCD donors. Characteristics and medication use of 409 potential cDCD donors admitted to the intensive care units (ICUs) were assessed. End‐of‐life decision‐making was made after a mean time of 97 hours after ICU admission and mostly during the day. Intracranial hemorrhage or ischemic stroke and a high APACHE IV score were associated with a short decision‐making process. Preserved brainstem reflexes, high Glasgow Coma Scale scores, or cerebral infections were associated with longer time to decision‐making. Our data also suggest that the organ donation request could be made shortly after the decision to stop active treatment and consent rates were not influenced by daytime or nighttime or by the duration of the ICU stay. John Wiley and Sons Inc. 2020-08-26 2020-12 /pmc/articles/PMC7754148/ /pubmed/32506559 http://dx.doi.org/10.1111/ajt.16104 Text en © 2020 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Communications Kotsopoulos, Angela M. Jansen, Nichon E. Vos, Piet Witjes, Marloes Volbeda, Meint Epker, Jelle L. Sonneveld, Hans P. C. Simons, Koen S. Bronkhorst, Ewald M. van der Hoeven, Hans G. Abdo, Wilson F. Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title | Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title_full | Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title_fullStr | Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title_full_unstemmed | Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title_short | Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
title_sort | determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754148/ https://www.ncbi.nlm.nih.gov/pubmed/32506559 http://dx.doi.org/10.1111/ajt.16104 |
work_keys_str_mv | AT kotsopoulosangelam determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT jansennichone determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT vospiet determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT witjesmarloes determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT volbedameint determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT epkerjellel determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT sonneveldhanspc determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT simonskoens determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT bronkhorstewaldm determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT vanderhoevenhansg determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors AT abdowilsonf determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors |